- Fecal Incontinence
|Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management
Nat Rev Gastroenterol Hepatol. 2023 Jun 2;1-15. doi: 10.1038/s41575-023-00794-z.Online ahead of print.
1Food & Mood Centre, IMPACT Institute, Deakin University Geelong, Melbourne, Victoria, Australia. email@example.com.
2Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
3Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
4Psychiatry and Mental Health, University of New South Wales, Sydney, New South Wales, Australia.
5School of Psychology, Deakin University Geelong, Melbourne, Victoria, Australia.
6Department of Medicine and Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Irritable bowel syndrome (IBS) affects 5-10% of the global population. Up to one-third of people with IBS also experience anxiety or depression. Gastrointestinal and psychological symptoms both drive health-care use in people with IBS, but psychological comorbidity seems to be more important for long-term quality of life. An integrated care approach that addresses gastrointestinal symptoms with nutrition and brain-gut behaviour therapies is considered the gold standard. However, best practice for the treatment of individuals with IBS who have a comorbid psychological condition is unclear. Given the rising prevalence of mental health disorders, discussion of the challenges of implementing therapy for people with IBS and anxiety and depression is critical. In this Review, we draw upon our expertise in gastroenterology, nutrition science and psychology to highlight common challenges that arise when managing patients with IBS and co-occurring anxiety and depression, and provide recommendations for tailoring clinical assessment and treatment. We provide best practice recommendations, including dietary and behavioural interventions that could be applied by non-specialists and clinicians working outside an integrated care model.